ESTRO 2024 - Abstract Book

S5658

RTT - Patient experience and quality of life

ESTRO 2024

Keywords: quality of life, patient well-being, radiotherapy

References:

1. Ministry of Health. The National Cancer Plan for the Maltese Islands 2017–2021 - saħħa [Internet]. 2023 [cited 2023 Jun 19]. Available from: https://health.gov.mt/publications/the-national-cancer-plan-for-the-maltese-islands 2017-2021/

2. Post MWM. Definitions of Quality of Life: What Has Happened and How to Move On. PubMed Central (PMC) [Internet]. 2014. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4257148/.

3. Seol KH, Bong SH, Kang DH, Kim JW. Factors Associated with the Quality of Life of Patients with Cancer Undergoing Radiotherapy. Psychiatry Investig. 2021 Jan;18(1):80-87.4. Sitlinger A, Zafar SY. Health-Related Quality of Life: The Impact on Morbidity and Mortality. Surg Oncol Clin N Am. 2018 Oct;27(4):675-684.

4. Sitlinger A, Zafar SY. Health-Related Quality of Life: The Impact on Morbidity and Mortality. Surg Oncol Clin N Am. 2018 Oct;27(4):675-684.

5. Scott, N. W., Fayers, P., Aaronson, N. K., Bottomley, A., de Graeff, A., Groenvold, M., Gundy, C., Koller, M., Petersen, M. A., Sprangers, M. AG., & EORTC Quality of Life Group (2008). EORTC QLQ-C30 Reference Values Manual. (2nd ed.) EORTC Quality of Life Group. http://groups.eortc.be/qol/downloads/ reference_values_manual2008.pdf

986

Digital Poster

The impact of side-effects on health-related quality of life: The professional perception

Danielle Fairweather 1 , Rachel Taylor 2 , Rita Simoes 1,3,4

1 University College London Hospitals NHS Foundation Trust, Radiotherapy and Proton Beam Therapy, London, United Kingdom. 2 University College London Hospitals NHS Foundation Trust, Centre for Nurse Midwife and AHP Research, London, United Kingdom. 3 The Institute of Cancer Research, Radiotherapy Research, London, United Kingdom. 4 RTTQA, Radiotherapy Research, London, United Kingdom

Purpose/Objective:

Health-related quality of life (HRQoL) is a crucial outcome measurement within research and is widely accepted as a primary outcome within cancer clinical trials. Assessing the burden of symptoms and side-effects is essential, as both the physical and psychosocial impact of cancer treatment can be both distressing and profound [1]. However, when clinician reported outcomes (CROs) are compared to patient-reported outcomes (PROs), healthcare professionals (HCPs) have been shown to under-report patient outcomes, with patients scoring themselves as more affected by side-effects than the professionals perceive [2].

This phenomenon has been shown within previous radiotherapy (RT) clinical trials such as the IMPORT LOW trial [3]. Although differences in perception exist, little is known about the professional perception of HRQoL within RT